Duolin
Team 2
Brand Personality
Brand Name: duolin
Year of Launch: 2001, February
Available as: Duolin Inhaler/ Rotacaps/Forte Rotacaps/ Forte Inhaler
By-line for the brand: Rapid Relief from Symptoms
Price and Composition:
No. Name of Brand Composition Dosage Pack MRP
1 Duolin Inhaler Levosalbutamol 50 mcg + Ipratropium 20 mcg 2 puff Q.I.D 200 MD 281.93
2 Duolin Forte Inhaler Levosalbutamol 50 mcg + Ipratropium 40 mcg 2 Puff T.I.D 200 MD 357.0
3 Duolin Rotacap Levosalbutamol 100 mcg + Ipratropium 40 mcg 1-2 Rotacap Q.I.D 200 MD 77.59
4 Duolin Forte Rotacap Levosalbutamol 100 mcg + Ipratropium 80 mcg 1 Rotacap T.I.D 30’s 136.29
Duolin
A combination of Levosalbutamol (ß2 agonist) and Ipratropium
(anticholinergic)
Levosalbutamol Ipratropium
0.8 – 2 min 5-15 mins
Onset of Action
Peak Response 30 minutes 1.5- 2 hours
Duration of Action 6-8 hours * 6-8 hours *
*As mentioned in GOLD 2019
Mode of Action
Levosalbutamol Ipratropium
Sympathetic Nervous Parasympathetic
System Nervous System
Blocks muscarinic
Stimulates ß2 receptors receptors
Prevents
Causes bronchodilation
bronchoconstriction
Prevents airways
Open up airways
from closing
ß2 agonists and anticholinergic achieve bronchodilation by different means,
using the sympathetic and parasympathetic nervous systems respectively
Total Lung Coverage: Deposits in Both Small and Large Airways
Ipratropium Levosalbutamol
Large Airways Small Airways
Why Combination Bronchodilators?
Offers better symptom control & improvement in lung function
1
Why Combination Bronchodilators?
Offers better symptom control & improvement in lung function
Percentage of patients with exacerbations
1 20%
18%
16%
14%
12%
10% Combination
8%
Salbutamol
6%
4%
2%
0%
Combination Salbutamol
• 85 day study, 347 patients received salbutamol, 358 received ipratropium + salbutamol combination
Chest 1999; 115:635-641
Dose response of ipratropium bromide
Objective -- To assess both the peak bronchodilation and the duration of the response, and the dose-response relationships of ipratropium
20 male patients Groups---
Randomised, double-
blind, placebo- Asthmatic 40 mcg ipratropium Efficacy end-points
controlled, parallel- Mean age 65 yrs 80 mcg ipratropium Mean change in FEV1
group study 4 days using MDls
FEV1 (Increase from baseline)
Conclusion : 80mcg 40%
35%
30% 28%
34%
Ipratropium shows 34%
25%
20%
15%
rise in FEV1 from baseline 10%
5%
0%
40 mcg 80 mcg
40 mcg 80 mcg
FEV1 – Forced expiratory volume in 1 sec FVC – Forced vital capacity Thorax, 1979, 34, 137-139
• 80 mcg Ipratropium offers better symptom control and
improvement in lung function
• 80 mcg Ipratropium may prolong the duration of
Summary: bronchodilatation
Duolin Fort • 80 mcg Ipratropium can also be used to optimize its
potential bronchodilating effects
• Significant bronchodilation with optimal doses might translate
into increased exercise capacity
• TID dosing of Duolin Forte Vs QID dosing of Duolin may offer
better patient compliance
Thanks